Hoek, J.; Bloemendal, K.M.; Van der Velden, L.-A.A.; Van Diessen, J.N.A.; Van Werkhoven, E.; Klop, W.M.C.; Tesselaar, M.E.T.
Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas. Cancers 2016, 8, 21.
https://doi.org/10.3390/cancers8020021
AMA Style
Hoek J, Bloemendal KM, Van der Velden L-AA, Van Diessen JNA, Van Werkhoven E, Klop WMC, Tesselaar MET.
Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas. Cancers. 2016; 8(2):21.
https://doi.org/10.3390/cancers8020021
Chicago/Turabian Style
Hoek, Jantien, Karen M. Bloemendal, Lilly-Ann A. Van der Velden, Judi N.A. Van Diessen, Erik Van Werkhoven, Willem M.C. Klop, and Margot E.T. Tesselaar.
2016. "Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas" Cancers 8, no. 2: 21.
https://doi.org/10.3390/cancers8020021
APA Style
Hoek, J., Bloemendal, K. M., Van der Velden, L. -A. A., Van Diessen, J. N. A., Van Werkhoven, E., Klop, W. M. C., & Tesselaar, M. E. T.
(2016). Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas. Cancers, 8(2), 21.
https://doi.org/10.3390/cancers8020021
